Peptide appearance Lyophilized form

Growth Factor Research

15 000+ verified orders

Tesamorlin + Ipamorelin

In stock

A two-component GHRH-analogue and secretagogue-peptide research blend.

Available strengths
99,00 €
Bundle & save
Buy in Bulk 10+ units35% off →

Arrives 12 – 16 November to Europe

We accept Visa Mastercard Apple Pay (when supported) Google Pay (when supported) Shown at checkout

Tesamorlin + Ipamorelin

99,00 €

Tesamorelin and Ipamorelin blend for paired GHRH and GHSR pathway studies.

SKU: ADRIA-TESAMORELIN-IPAMORELIN Categories: , ,

Research overview

Tesamorlin + Ipamorelin

Tesamorelin + Ipamorelin combines a stabilized GHRH analogue with the pentapeptide Ipamorelin.

Each component retains its own sequence, receptor context, and analytical identity within the declared blend. The listed sources are a research starting point rather than a substitute for product evidence: the supplied material's exact form, lot, and measured characteristics must be established through its signed analytical record.

Compound information

Specifications

Molecular profile

Sequence
Tesamorelin: trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Molecular mass
Tesamorelin: 5135.9 g/mol; Ipamorelin: 711.9 g/mol.
CAS number
Tesamorelin: 218949-48-5; Ipamorelin: 170851-70-4.
Molecular formula
Tesamorelin: C221H366N72O67S; Ipamorelin: C38H49N9O5.

Material record

Physical appearance
White to off-white lyophilized powder
Solubility
Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
Product note
Two-component research blend supplied strictly for research use only.

Laboratory care

Handling

Peptides in transport

Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.

Storage of lyophilized peptides

Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Up to 3 months
  • Refrigerated (2–8 °C): Up to 6 months
  • Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)

Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.

Storage of reconstituted peptides

Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.

The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Avoid prolonged storage
  • Refrigerated (2–8 °C): Typically 4–8 weeks
  • Frozen (-20 °C or below): Up to 3–4 months

To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.

Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.

Analytical documentation

Tests

On request

Documentation is available on request

Contact us for the current record for this strength. We never substitute a generic or mismatched certificate.

Your batch is confirmed when your order is allocated.
See all test results

Signed certificate

Source record

References

National Center for Biotechnology Information

PubChem Compound Summary: Tesamorelin

Identity record for the Tesamorelin component.

PubChem View source ↗

National Center for Biotechnology Information

PubChem Compound Summary: Ipamorelin

Identity record for the Ipamorelin component.

PubChem View source ↗

Russo SC, Ockene MW, Arpante AK, et al. · 2024

Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors

Primary clinical research report for the Tesamorelin component.

AIDS · 10.1097/qad.0000000000003965 View source ↗

Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S · 2010

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data

The Journal of clinical endocrinology and metabolism View source ↗

Stanley TL, Fourman LT, Feldpausch MN, Purdy J, Zheng I, Pan CS, Aepfelbacher J, Buckless C, Tsao A, Kellogg A, Branch K, Lee H, Liu CY, Corey KE, Chung RT, Torriani M, Kleiner DE, Hadigan CM, Grinspoon SK · 2019

Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial

The lancet. HIV View source ↗

Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, Vitiello MV · 2012

Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial

Archives of neurology View source ↗

Lauritzen L, Amundsen ID, Damsgaard CT, Lind MV, Schnurr TM, Hansen T, Michaelsen KF, Vogel U · 2019

FADS and PPARG2 Single Nucleotide Polymorphisms are Associated with Plasma Lipids in 9-Mo-Old Infants

The Journal of nutrition View source ↗

Sharma G, Ojha R, Noguera-Ortega E, Rebecca VW, Attanasio J, Liu S, Piao S, Lee JJ, Nicastri MC, Harper SL, Ronghe A, Jain V, Winkler JD, Speicher DW, Mastio J, Gimotty PA, Xu X, Wherry EJ, Gabrilovich DI, Amaravadi RK · 2020

PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma

JCI insight View source ↗

Customer reviews

4.6/5100+ reviews
View on Trustpilot ↗Checked 7 Oct 2026

had a communication issue with my order at first and was worried about the delay. The team got back to me and the problem was resolved. I'm satisfied with the products and happy with how it turned out in the end. Thank you for sorting it out.

Read full review →

Personale cordiale è sempre disponibile, veloci nella consegna Peccato che non c'è la possibilità di pagare con la carta

Read full review →

Häirib see, et iga uue tellimuse juures on jälle uus pangakonto number, mida ma pean käsitsi igakord uuesti sisestama.

Read full review →